Drug Shortage Report for APO-SITAGLIPTIN/METFORMIN XR
| Report ID | 178775 |
| Drug Identification Number | 02506289 |
| Brand name | APO-SITAGLIPTIN/METFORMIN XR |
| Common or Proper name | SITAGLIPTAN/METFORMIN |
| Company Name | APOTEX INC |
| Market Status | MARKETED |
| Active Ingredient(s) | METFORMIN HYDROCHLORIDE SITAGLIPTIN |
| Strength(s) | 1000MG 50MG |
| Dosage form(s) | TABLET (EXTENDED-RELEASE) |
| Route of administration | ORAL |
| Packaging size | 60 BTL |
| ATC code | A10BD |
| ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2022-12-13 |
| Estimated end date | 2023-01-27 |
| Actual end date | 2023-01-19 |
| Shortage status | Resolved |
| Updated date | 2023-01-20 |
| Company comments | Increase in demand |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
| Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2023-01-20 | French | Compare |
| v7 | 2023-01-20 | English | Compare |
| v6 | 2022-12-23 | French | Compare |
| v5 | 2022-12-23 | English | Compare |
| v4 | 2022-12-19 | French | Compare |
| v3 | 2022-12-19 | English | Compare |
| v2 | 2022-12-16 | French | Compare |
| v1 | 2022-12-16 | English | Compare |
Showing 1 to 8 of 8